Nabeel Abdulrahman
Overview
Explore the profile of Nabeel Abdulrahman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suleiman M, Al Najjar A, Zakaria Z, Ahmed R, Yalcin H, Korashy H, et al.
J Cardiovasc Transl Res
. 2023 Sep;
17(2):334-344.
PMID: 37725271
Targeted therapy, such as tyrosine kinase inhibitors (TKIs), has been approved to manage various cancer types. However, TKI-induced cardiotoxicity is a limiting factor for their use. This issue has raised...
2.
Abdulrahman N, Leo R, Boumenar H, Ahmad F, Mateo J, Jochebeth A, et al.
Leuk Lymphoma
. 2023 Sep;
64(14):2236-2248.
PMID: 37708450
Cutaneous T cell lymphoma (CTCL) is a varied group of neoplasms that affects the skin. Acquired resistance against chemotherapeutic drugs and associated toxic side effects are limitations that warrant search...
3.
Ansari A, Ahmad F, Raheed T, Jochebeth A, Mateo J, Abdulrahman N, et al.
Int Immunopharmacol
. 2023 Aug;
124(Pt A):110831.
PMID: 37633240
The precise mechanism of macrolide antibiotic azithromycin (AZM) mediated CD4+ T cell suppression is not fully understood. Given the crucial role of co-stimulatory signaling in T-lymphocyte function, we tested in...
4.
Ali R, Idoudi S, Abdulrahman N, Mraiche F
Curr Pharm Teach Learn
. 2023 Jul;
15(7):654-660.
PMID: 37481456
Introduction: Pharmaceutical biotechnology involves using the principles of biotechnology to develop drugs. With the rapid increase in biopharmaceutical products being developed and approved for use, educating pharmacy students about biotechnological...
5.
Abdulrahman N, Ibrahim M, Joseph J, Elkoubatry H, Al-Shamasi A, Rayan M, et al.
Mol Cell Biochem
. 2022 Mar;
477(6):1865-1872.
PMID: 35334035
Diabetes mellitus (DM)-induced cardiac morbidities have been the leading cause of death among diabetic patients. Recently, sodium-glucose cotransporter-2 (SGLT-2) inhibitors including empagliflozin (EMPA), which have been approved for the treatment...
6.
Moustafa D, Imran Z, Ismail R, Rayan M, Gadeau A, Eldassouki H, et al.
Mol Biol Rep
. 2022 Feb;
49(3):2321-2324.
PMID: 35102475
Numerous studies demonstrate parallels between CVD, type 2 diabetes mellitus (T2DM) and COVID-19 pathology, which accentuate pre-existing complications in patients infected with COVID-19 and potentially exacerbate the infection course. Antidiabetic...
7.
Riaz S, Abdulrahman N, Uddin S, Jabeen A, Gadeau A, Fliegel L, et al.
Eur J Pharmacol
. 2020 Aug;
888:173420.
PMID: 32781168
Previous studies have established the role of Na/H exchanger isoform-1 (NHE1) and cathepsin B (Cat B) in the development of cardiomyocyte hypertrophy (CH). Both NHE1 and Cat B are activated...
8.
Abdulrahman N, Siveen K, Joseph J, Osman A, Yalcin H, Hasan A, et al.
J Pharm Pharmacol
. 2020 Jul;
72(11):1536-1545.
PMID: 32667058
Objective: Cisplatin is a standard treatment approach against lung adenocarcinoma. Resistance to cisplatin and the toxic side effects of cisplatin continue to remain a challenge. Combining drugs with different mechanisms...
9.
Saadaoui I, Rasheed R, Abdulrahman N, Bounnit T, Cherif M, Jabri H, et al.
Mar Drugs
. 2020 Apr;
18(4).
PMID: 32276401
Lung cancer is one of the major causes of death worldwide. Natural molecules with anti-lung cancer potential are of a great interest and considered as very promising alternative to substitute...
10.
Abdelaziz Mohamed I, Gadeau A, Hasan A, Abdulrahman N, Mraiche F
Cells
. 2019 Dec;
8(12).
PMID: 31816901
Osteopontin (OPN) is recognized for its significant roles in both physiological and pathological processes. Initially, OPN was recognized as a cytokine with pro-inflammatory actions. More recently, OPN has emerged as...